| pubmed-article:17606735 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0079613 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0034790 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0026189 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C1705822 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C1705180 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C1536991 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:17606735 | lifeskim:mentions | umls-concept:C0348011 | lld:lifeskim |
| pubmed-article:17606735 | pubmed:issue | 13 | lld:pubmed |
| pubmed-article:17606735 | pubmed:dateCreated | 2007-7-3 | lld:pubmed |
| pubmed-article:17606735 | pubmed:abstractText | Donor T cells directed to hematopoietic minor histocompatibility antigens (mHag) are appealing tools for adoptive immunotherapy of hematological malignancies after allogeneic stem cell transplantation (allo-SCT). Toward the development of a convenient strategy for ex vivo generation of human leukocyte antigen (HLA) class II--restricted mHag-specific T cells, we evaluated the feasibility of rebuilding mHag-specific T cell functions in donor-derived recall antigen-specific T cells via T cell receptor (TCR) transfer. | lld:pubmed |
| pubmed-article:17606735 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17606735 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17606735 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17606735 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17606735 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17606735 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17606735 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:17606735 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:17606735 | pubmed:author | pubmed-author:MutisTunaT | lld:pubmed |
| pubmed-article:17606735 | pubmed:author | pubmed-author:LokhorstHenkH | lld:pubmed |
| pubmed-article:17606735 | pubmed:author | pubmed-author:BloemAndriesA | lld:pubmed |
| pubmed-article:17606735 | pubmed:author | pubmed-author:IvanovRomanR | lld:pubmed |
| pubmed-article:17606735 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:17606735 | pubmed:author | pubmed-author:SpaapenRobber... | lld:pubmed |
| pubmed-article:17606735 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17606735 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17606735 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:17606735 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17606735 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17606735 | pubmed:pagination | 4009-15 | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:meshHeading | pubmed-meshheading:17606735... | lld:pubmed |
| pubmed-article:17606735 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17606735 | pubmed:articleTitle | Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy. | lld:pubmed |
| pubmed-article:17606735 | pubmed:affiliation | Authors' Affiliations: Departments of Clinical Chemistry and Haematology, Immunology, and Haematology, University Medical Center Utrecht, the Netherlands. | lld:pubmed |
| pubmed-article:17606735 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17606735 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17606735 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17606735 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17606735 | lld:pubmed |
